Clinical Trials Directory

Trials / Unknown

UnknownNCT02256579

Utility of Urinary beta2 Microglobulin as an Early Marker of Renal Dysfunction in Vietnamese HIV-Infected Patients

Vietnam-Japan Cooperative Research on Prognosis of HIV-1-infection -Clinical Utility of Urinary beta2 Microglobulin as an Early Marker of Renal Dysfunction Caused by Use of Tenofovir in Vietnamese HIV-Infected Patients-

Status
Unknown
Phase
Study type
Observational
Enrollment
1,800 (estimated)
Sponsor
National Center for Global Health and Medicine, Japan · Other Government
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

This study is to investigate clinical utility of beta2 microglobulin as an early marker for renal dysfunction caused by Tenofovir in Vietnamese HIV-infected patients.

Detailed description

An observational study to investigate clinical utility of beta2 microglobulin as an early marker for renal dysfunction caused by Tenofovir in Vietnamese HIV-infected patients.

Conditions

Timeline

Start date
2014-10-01
Primary completion
2016-11-01
Completion
2017-03-01
First posted
2014-10-03
Last updated
2014-10-03

Source: ClinicalTrials.gov record NCT02256579. Inclusion in this directory is not an endorsement.